SCHEMBL15499089

SCHEMBL15499089

CCc1cc(/C=C/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A11 Q9UPY5 3/20 0.70
BRD4 O60885 7/20 0.56
POLB P06746 1/20 0.51
BRD3 Q15059 1/20 0.51
CREBBP Q92793 1/20 0.51
BRD7 Q9NPI1 1/20 0.51
KDM4E B2RXH2 6/20 0.50
ALDH1A1 P00352 3/20 0.50
LMNA P02545 3/20 0.50
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
ABCC3 O15438 1/20 0.50
ABCC4 O15439 1/20 0.50
USP2 O75604 1/20 0.50
SLCO2B1 O94956 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
MMP1 P03956 1/20 0.50
ABCB1 P08183 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15499066 0.84 SLC7A11 (0.58) SLC7A11BRD4POLBBRD3CREBBP
SCHEMBL15499078 0.83 KDM4E (0.57) BRD4POLBBRD3CREBBPBRD7
SCHEMBL8067761 0.82 SLC7A11 (1.00) SLC7A11BRD4POLBKDM4EALDH1A1
SCHEMBL8068359 0.82 SLC7A11 (1.00) SLC7A11BRD4POLBKDM4EALDH1A1
SCHEMBL8069397 0.82 SLC7A11 (0.79) SLC7A11BRD4POLBBRD3CREBBP
SCHEMBL8069398 0.82 SLC7A11 (0.79) SLC7A11BRD4POLBBRD3CREBBP
SCHEMBL15496562 0.81 BRD4 (0.71) SLC7A11BRD4POLBBRD3CREBBP
SCHEMBL15496600 0.79 SLC7A11 (0.62) SLC7A11BRD4POLBBRD3CREBBP
SCHEMBL8072369 0.78 SLC7A11 (0.69) SLC7A11BRD4POLBBRD3CREBBP
SCHEMBL8072366 0.78 SLC7A11 (0.69) SLC7A11BRD4POLBBRD3CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140066410-A1 INHIBITORS OF BROMODOMAINS AS MODULATORS OF GENE EXPRESSION ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2014-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140066410-A1 INHIBITORS OF BROMODOMAINS AS MODULATORS OF GENE EXPRESSION NFKBIA, NFKB2, IKBKG SLC7A11 4544/4885BRD4 23/4885POLB 96/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.